Ruben Niesvizky, M.D.

Dr. Niesvizky is Professor of Medicine at Weill Cornell Medical College and at NewYork Presbyterian Hospital/Weill Cornell Medical Center in Manhattan. He also serves as Director of the Multiple Myeloma Center at NewYork Presbyterian Hospital/Weill Cornell Medical Center. After receiving a medical degree from National University of Mexico, Dr. Niesvizky did a research fellowship in cell biology-granulocytopoiesis and an internal medicine residency at the National Institute of Nutrition in Mexico. He then completed fellowships in New York: one (hematology) at Mount Sinai Medical Center and one (hematology/medical oncology) at Memorial Sloan-Kettering Cancer Center. He has written more than 100 articles, editorials, chapters, and abstracts published in journals such as New England Journal of Medicine, Blood and Leukemia & Lymphoma, most recently on topics such as the treatment of myeloma and Waldenstrom's macroglobulinemia. He is the recipient of various grants and awards from the National Cancer Institute and the Leukemia and Lymphoma Society, including a K23 award and three translational research grants. He received the 2007 Investigator Award of the Michael Wolk Heart Foundation. He has been voted by pears as “Best Doctors” in 2013 and appeared in New York Magazine as Hematolgy “Top Doctors” 2014. A frequent lecturer, Dr Niesvizky regularly presents at annual meetings of the American Society of Hematology and the American Society of Clinical Oncology, of which he is also a member. He is an active member of the International Myeloma Working Group which defines standards of research and practice in myeloma. He is an active participant in clinical trials of promising new drugs and medical procedures for the treatment of myeloma, lymphoma, and related hematologic disorders.